# A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs

> **NCT06003114** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 472 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Palbociclib

## Key facts

- **NCT ID:** NCT06003114
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-06
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-02-22
- **Target enrollment:** 472 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06003114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06003114, "A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06003114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*